Edition:
United Kingdom

Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

49.77USD
8:49pm GMT
Change (% chg)

$0.95 (+1.95%)
Prev Close
$48.82
Open
$49.32
Day's High
$50.10
Day's Low
$49.08
Volume
60,666
Avg. Vol
112,051
52-wk High
$50.10
52-wk Low
$27.94

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.35 December 17 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.80 1.80 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5 137.99 152.00 118.00 --
Quarter Ending Jun-18 5 149.28 173.00 107.50 --
Year Ending Dec-18 6 694.68 743.00 559.30 581.45
Earnings (per share)
Quarter Ending Mar-18 5 0.35 0.45 0.20 --
Quarter Ending Jun-18 5 0.41 0.64 0.20 --
Year Ending Dec-18 5 2.32 2.81 2.00 2.38
LT Growth Rate (%) 2 20.00 22.00 18.00 22.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 124.55 149.43 24.88 19.98
Quarter Ending Jun-17 111.57 100.77 10.79 9.68
Quarter Ending Mar-17 116.40 116.86 0.46 0.39
Quarter Ending Dec-16 120.45 151.66 31.21 25.91
Quarter Ending Sep-16 112.30 142.91 30.61 27.26
Earnings (per share)
Quarter Ending Sep-17 0.41 0.73 0.32 77.18
Quarter Ending Jun-17 0.26 0.13 0.13 49.22
Quarter Ending Mar-17 0.31 0.29 0.02 5.69
Quarter Ending Dec-16 0.48 0.74 0.26 52.89
Quarter Ending Sep-16 0.38 0.58 0.20 54.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 137.99 134.49 130.09 130.09 --
Quarter Ending Jun-18 149.28 144.98 139.98 139.98 --
Year Ending Dec-18 694.68 673.28 659.45 638.68 581.45
Earnings (per share)
Quarter Ending Mar-18 0.35 0.38 0.41 0.40 --
Quarter Ending Jun-18 0.41 0.43 0.47 0.44 --
Year Ending Dec-18 2.32 2.42 2.56 2.29 2.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 1 0 2 0
Quarter Ending Jun-18 1 0 2 0
Year Ending Dec-18 2 0 3 0
Earnings
Quarter Ending Mar-18 0 1 0 2
Quarter Ending Jun-18 0 1 0 2
Year Ending Dec-18 0 1 0 2